Akzo Nobel posts fifth straight quarter of margin growth in Q2 2026

Akzo Nobel reported its Q2 2026 financial results, showing 2 % organic sales growth while reported revenue fell 1 % to €2.589 billion. Operating income rose 17 % to €251 million and adjusted EBITDA reached €398 million, lifting the adjusted EBITDA margin to 15.4 % from 15.0 % a year earlier. Net cash from operating activities was €170 million.

For the first half of 2026, organic sales were flat and reported revenue declined 5 % due to adverse currency effects. Half‑year operating income increased to €428 million and the adjusted EBITDA margin improved to 14.9 % from 14.3 % the prior year, with organic adjusted EBITDA growth of €39 million driven by pricing.

CEO Greg Poux‑Guillaume highlighted continued pricing strength, cost efficiency, and progress on sustainability, noting a 50 % reduction in the company’s operational carbon emissions four years ahead of its 2030 target. He also said the planned merger with Axalta is on schedule, with a shareholder vote on 5 August and an expected closing at the end of 2026 or early 2027. The firm reaffirmed its full‑year outlook, targeting at least €1.47 billion of adjusted EBITDA, excluding any merger effects.